Failure to Thrive — Mobile-Thrive - A Family Self-Management Approach to Failure to Thrive
Citation(s)
Atalay A, McCord M Characteristics of failure to thrive in a referral population: implications for treatment. Clin Pediatr (Phila). 2012 Mar;51(3):219-25. doi: 10.1177/0009922811421001. Epub 2011 Oct 12.
Berlin KS, Davies WH, Silverman AH, Rudolph CD Assessing family-based feeding strategies, strengths, and mealtime structure with the Feeding Strategies Questionnaire. J Pediatr Psychol. 2011 Jun;36(5):586-95. doi: 10.1093/jpepsy/jsp107. Epub 2009 Dec 7.
Black MM, Krishnakumar A Predicting longitudinal growth curves of height and weight using ecological factors for children with and without early growth deficiency. J Nutr. 1999 Feb;129(2S Suppl):539S-543S. doi: 10.1093/jn/129.2.539S.
Dowdney L, Skuse D, Morris K, Pickles A Short normal children and environmental disadvantage: a longitudinal study of growth and cognitive development from 4 to 11 years. J Child Psychol Psychiatry. 1998 Oct;39(7):1017-29.
Drotar D, Sturm L Prediction of intellectual development in young children with early histories of nonorganic failure-to-thrive. J Pediatr Psychol. 1988 Jun;13(2):281-96.
Dykman RA, Casey PH, Ackerman PT, McPherson WB Behavioral and cognitive status in school-aged children with a history of failure to thrive during early childhood. Clin Pediatr (Phila). 2001 Feb;40(2):63-70.
Garro A, Thurman SK, Kerwin ME, Ducette JP Parent/caregiver stress during pediatric hospitalization for chronic feeding problems. J Pediatr Nurs. 2005 Aug;20(4):268-75.
Gazmararian JA, Elon L, Yang B, Graham M, Parker R Text4baby program: an opportunity to reach underserved pregnant and postpartum women? Matern Child Health J. 2014 Jan;18(1):223-232. doi: 10.1007/s10995-013-1258-1.
Mendez MA, Adair LS Severity and timing of stunting in the first two years of life affect performance on cognitive tests in late childhood. J Nutr. 1999 Aug;129(8):1555-62.
Mitchell WG, Gorrell RW, Greenberg RA Failure-to-thrive: a study in a primary care setting. Epidemiology and follow-up. Pediatrics. 1980 May;65(5):971-7.
Panepinto JA, Hoffmann RG, Pajewski NM A psychometric evaluation of the PedsQL Family Impact Module in parents of children with sickle cell disease. Health Qual Life Outcomes. 2009 Apr 16;7:32. doi: 10.1186/1477-7525-7-32.
Rumberger JS, Dansky K Is there a business case for telehealth in home health agencies? Telemed J E Health. 2006 Apr;12(2):122-7.
Ryan P, Sawin KJ The Individual and Family Self-Management Theory: background and perspectives on context, process, and outcomes. Nurs Outlook. 2009 Jul-Aug;57(4):217-225.e6. doi: 10.1016/j.outlook.2008.10.004.
Skuse D, Pickles A, Wolke D, Reilly S Postnatal growth and mental development: evidence for a "sensitive period". J Child Psychol Psychiatry. 1994 Mar;35(3):521-45. Review.
Skuse DH Non-organic failure to thrive: a reappraisal. Arch Dis Child. 1985 Feb;60(2):173-8. Review.
Wright CM, Callum J, Birks E, Jarvis S Effect of community based management in failure to thrive: randomised controlled trial. BMJ. 1998 Aug 29;317(7158):571-4.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.